The data are quite contrast to those of malignant melanomas, where approximately 90% of BRAF mutations involved V599, raising the possibility that the contribution of BRAF mutations in the development of NHL might be different from that of malignant melanoma. Here, BRAF is linked to non-Hodgkin lymphoma.